| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8adaddc602ad7cb7f9e2d550681bb36d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2563-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2527-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2523-107 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6806 |
| filingDate |
2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e26506320b41d659a78420d47d3e417e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9eef4d9277dbb6f6499d38fbc57bcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16c4f341cec339748d611b8b1aa6c66b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8a38f06b94efff7ce9ccee50ec5e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d1c29df22be87a607688276d901ee89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2dfa762b864a182b16d56fb40eac2ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7579c566c794a6867380267d78921625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f261db6655b8b5938836c1c963a84a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ba9cdede0dad4c069c2c38b3c01e501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e7aa8272c978c5564299adae085a9e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e05467b24f72984281efc35948ea23 |
| publicationDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021158556-A1 |
| titleOfInvention |
Biotin-streptavidin cleavage composition and library fragment cleavage |
| abstract |
An example of a biotin-streptavidin cleavage composition includes a formamide reagent and a salt buffer. The formamide reagent is present in the biotin-streptavidin cleavage composition in an amount ranging from about 10% to about 50%, based on a total volume of the biotin-streptavidin cleavage composition. The salt buffer makes up the balance of the biotin-streptavidin cleavage composition. In some examples, the biotin-streptavidin cleavage composition is used to cleave library fragments from a solid support. In other examples, other mechanisms are used to cleave library fragments from a solid support. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023183325-A1 |
| priorityDate |
2020-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |